1. Home
  2. HCM vs BTDR Comparison

HCM vs BTDR Comparison

Compare HCM & BTDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • BTDR
  • Stock Information
  • Founded
  • HCM 2000
  • BTDR 2021
  • Country
  • HCM Hong Kong
  • BTDR Singapore
  • Employees
  • HCM N/A
  • BTDR N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • BTDR EDP Services
  • Sector
  • HCM Health Care
  • BTDR Technology
  • Exchange
  • HCM Nasdaq
  • BTDR Nasdaq
  • Market Cap
  • HCM 2.5B
  • BTDR 3.0B
  • IPO Year
  • HCM N/A
  • BTDR N/A
  • Fundamental
  • Price
  • HCM $13.89
  • BTDR $12.86
  • Analyst Decision
  • HCM Hold
  • BTDR Strong Buy
  • Analyst Count
  • HCM 1
  • BTDR 10
  • Target Price
  • HCM $19.00
  • BTDR $19.35
  • AVG Volume (30 Days)
  • HCM 62.8K
  • BTDR 5.4M
  • Earning Date
  • HCM 03-19-2025
  • BTDR 05-15-2025
  • Dividend Yield
  • HCM N/A
  • BTDR N/A
  • EPS Growth
  • HCM N/A
  • BTDR N/A
  • EPS
  • HCM 0.04
  • BTDR N/A
  • Revenue
  • HCM $630,201,000.00
  • BTDR $300,404,000.00
  • Revenue This Year
  • HCM $14.86
  • BTDR $67.96
  • Revenue Next Year
  • HCM $19.54
  • BTDR $97.79
  • P/E Ratio
  • HCM $63.20
  • BTDR N/A
  • Revenue Growth
  • HCM N/A
  • BTDR N/A
  • 52 Week Low
  • HCM $11.51
  • BTDR $5.40
  • 52 Week High
  • HCM $21.50
  • BTDR $26.99
  • Technical
  • Relative Strength Index (RSI)
  • HCM 50.07
  • BTDR 48.95
  • Support Level
  • HCM $13.13
  • BTDR $14.19
  • Resistance Level
  • HCM $13.66
  • BTDR $15.05
  • Average True Range (ATR)
  • HCM 0.36
  • BTDR 1.07
  • MACD
  • HCM 0.05
  • BTDR -0.23
  • Stochastic Oscillator
  • HCM 81.25
  • BTDR 13.48

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About BTDR Bitdeer Technologies Group

Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. The Company does not conduct any substantive operations on its own but conducts its primary operations through its subsidiaries. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway, Bhutan and Singapore.

Share on Social Networks: